UCB SA UNC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Parkinson's disease, Crohn's disease, psoriasis, and autoimmune condition…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryBelgium
Employees9,765
TickerUNC
Statistics
Market Cap$49.70B
Revenue (TTM)—
Net Income—
Net Margin—
EPS—
P/E80.45
P/S—
P/B4.57
EV/EBITDA18.95
ROE14.9%
Dividend Yield—
Price$291.64
Data: Twelve Data · Revenue = mcap / P/S